The morphological and molecular diagnosis of lung cancer;Morphologische und molekulare diagnostik des lungenkarzinoms

Deutsches Arzteblatt

Volumn 108, Issue 31-32, 2011, Pages 525-531

  Petersen, Iver ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

GENOME ANALYSIS; HISTOPATHOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; MOLECULAR DIAGNOSIS; MORPHOLOGY; PHENOTYPE; PROGNOSIS; REVIEW; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; WORLD HEALTH ORGANIZATION;

ADENOCARCINOMA; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; GENETIC MARKERS; GENOTYPE; HUMANS; LUNG; LUNG NEOPLASMS; MOLECULAR DIAGNOSTIC TECHNIQUES; NEOPLASM STAGING; PLOIDIES; PROGNOSIS;

EID: 80053578673     PISSN: 00121207     EISSN: 01722107     Source Type: Journal    
DOI: 10.3238/arztebl.2011.0525     Document Type: Review

References (20)

1. th revised edition. Berlin 2010; www.gekid.de.
2. Goeckenjan G, Sitter H, Thomas M, et al.: Prävention, Diagnose, Therapie und Nachsorge des Lungenkarzinoms. Interdisziplinäre S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Krebsgesellschaft. Pneumologie 2010; 64(Suppl 2): e1-e164.
3. Travis WD, Brambilla E, Müller-Hermeling K, Harris CC (eds): World Health Organization Classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARCPress 2004.
4. Klein F, Amin Kotb WFM, Petersen I: Incidence of human papilloma virus in lung cancer. Lung Cancer 2009; 65: 13-8.
5. Petersen I, Amin Kotb WFM, Friedrich KH, Schlüns K, Böcking A, Dietel M: Core classification of lung cancer: Correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 2009; 65: 312-8.
6. Nakazato Y, Minami Y, Kobayashi H, et al.: Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis. Cancer 2010; 116: 2011-9.
7. Junker K, Petersen I: Kleinzelliges Lungenkarzinom: Pathologie und Molekularpathologie. Onkologe 2008; 14: 762-73.
8. Travis WD, Brambilla E, Noguchi M, et al.: IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: 244-85.
9. Müller KM, Wiethege T: Pathology, classification, and staging of malignant lung tumors. Radiologe 2004; 44: 415-26.
10. Neben K, Hübner G, Folprecht G, Jäger D, Krämer A: Metastases in the absence of a primary tumor: Advances in the diagnosis and treatment of CUP syndrome. Dtsch Arztebl Int 2008; 105: 733-40.
11. Weichert W, Schewe C, Denkert C, Morawietz L, Dietel M, Petersen I: Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 2009; 33: 513-20.
12. Garber ME, Troyanskaya OG, Schluens K, et al.: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001; 98: 13784-9. (Pubitemid 33115976)
13. Meyerson M, Franklin WA, Kelley MJ: Molecular classification and molecular genetics of human lung cancers. Semin Oncol 2004; 31(Suppl 1): 4-19. (Pubitemid 38241016)
14. Bremnes RM, Veve R, Hirsch FR, Franklin WA: The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002; 36: 115-24. (Pubitemid 34302891)
15. Beer DG, Kardia SL, Huang CC, et al.: Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8: 816-24.
16. Yanagisawa K, Tomida S, Shimada Y, Yatabe Y, Mitsudomi T, Takahashi T: A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancer. J Natl Cancer Inst 2007; 99: 858-67.
17. Chen HY, Yu SL, Chen CH, et al.: A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356: 11-20.
18. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM, et al.: Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 2008; 14: 822-7.
19. Motoi N, Szoke J, Riely GJ, et al.: Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 2008; 32: 810-27.
20. Thomas RK, Weir B, Meyerson M: Genomic approaches to lung cancer. Clin Cancer Res 2006; 12: 4384s-91s. (Pubitemid 44197186)